Integrative analysis of the potential of DISP3 as a biomarker for thyroid cancer
Abstract Background: Thyroid cancer (THCA) is a common endocrine malignancy with diverse prognostic outcomes. The role of dispatched RND transporter family member 3 (DISP3) in tumorigenesis remains unclear. This study aimed to investigate DISP3’s biomarker potential in THCA. Methods: DISP3 expression in THCA and its correlation with clinicopathological features was analyzed from The Cancer Genome Atlas (TCGA) datasets. Functional enrichment, immune infiltration, genomic alterations and drug sensitivity analyses were performed. Prognostic value was evaluated by Kaplan-Meier analysis, Cox regression, and
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in